Translating Research Into Action for Diabetes (TRIAD) Legacy Study

将糖尿病研究转化为行动 (TRIAD) 遗产研究

基本信息

项目摘要

DESCRIPTION OF THE PROJECT: The Kaiser Permanente Northern California (KPNC)'s Division of Research proposes to continue participation in the TRIAD Study through its Legacy FOA. TRIAD has proven many new insights into how both system and patient factors influence the quality and outcomes of diabetes care in health systems. Many "second generation" questions have been raised and the TRIAD datasets allow for study of some of these questions. The KPNC team (Drs. Selby, Karter, Ferrara, and Schmittdiel) all hope to remain involved during TRIAD and have each contributed to the six paper proposals included. These proposals focus squarely on advancing our understanding of health disparities in these insured populations. They examine both system and patient factors as potential determinants of disparities. Two proposals examine the potential effects of system-level interventions (mail order pharmacy (#3) and incentives to use mail order pharmacy (#1)) on patient behaviors and outcomes, with specific attention to differences by race/ethnicity and socioeconomic status. Two proposals (#'s 4 and 6) look at patient factors (i.e., weight gain) and how differential weight gain in persons with diabetes and women with gestational diabetes affects patterns of disparities in CVD risk factor levels. One proposal (#5) looks at a physician factor, the awareness of medication non-adherence, by primary care physicians. The final proposal (#2) is a methodologic inquiry into the mechanisms of health disparities. The KPNC TRIAD investigator team has proven its engagement with TRIAD by first-authoring 16 of TRIAD's 64 papers, and by making additional KPNC data available to colleagues from other TRCs for site specific projects (e.g., Mail Order Pharmacy Project, Medicare Part D Project, Insulin Starts Project). The team hopes to pursue our paper proposals and those proposed from other TRIAD TRCs in the same collaborative fashion that TRIAD has established, to continue participating on (and continuing to chair, if requested) the Steering Committee. It is also committed to preserving and practicing secure data sharing of the previously collected TRIAD data and to disseminating study findings back to the health systems that provided the data as well as to the scientific community through publications and presentations.
该项目的描述:Kaiser Permanente North California(KPNC)的研究部提议通过其传统FOA继续参与三合会研究。三合会证明了许多新的见解,即系统和患者因素如何影响卫生系统中糖尿病护理的质量和结果。已经提出了许多“第二代”问题,三合会数据集允许研究其中一些问题。 KPNC团队(Selby博士,Karter,Ferrara和Schmittdiel)都希望在Triad期间继续参与 并为包括的六个论文提案做出了贡献。这些提案正专注于促进我们对这些被保险人群中健康差异的理解。他们将系统和患者因素视为差异的潜在决定因素。两项建议研究了系统级干预措施(邮购药房(#3)和使用邮购药房(#1))对患者行为和结果的潜在影响,并特别注意种族/誉和社会经济状况的差异。两项建议(#4和6)研究患者因素(即体重增加)以及糖尿病患者和妊娠糖尿病女性的体重增加如何影响CVD风险因素水平的差异模式。一 提案(#5)着眼于医师的医师因素,对药物不遵守药物的意识。最终提案(#2)是对健康差异机制的方法论研究。 KPNC Triad研究者团队通过首次撰写了Triad的64篇论文,证明了其与Triad的参与,并通过将来自其他TRC的同事提供额外的KPNC数据(例如,邮购Pharmacy Promastion,Medicare Part D Part D Project,Insulin Start Project)。该团队希望以与Triad所建立的合作方式相同的方式提出我们的论文提案,以及其他三合会TRC提出的建议,继续参与(并继续主持) 指导委员会。它还致力于保存和练习先前收集的三合会数据的安全数据共享,并通过出版物和演示文稿将研究结果传播回提供数据以及科学界提供数据的卫生系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOE Vandiver SELBY其他文献

JOE Vandiver SELBY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOE Vandiver SELBY', 18)}}的其他基金

Learnings in Diabetes Prevention from an Integrated Delivery System
从综合输送系统预防糖尿病的经验教训
  • 批准号:
    8065273
  • 财政年份:
    2010
  • 资助金额:
    $ 12.2万
  • 项目类别:
Effectiveness of Immediate vs. Delayed Use of Metformin in New-Onset T2 Diabetes
立即使用二甲双胍与延迟使用二甲双胍治疗新发 T2 糖尿病的疗效
  • 批准号:
    7820749
  • 财政年份:
    2009
  • 资助金额:
    $ 12.2万
  • 项目类别:
Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk
反馈治疗强化数据以降低心血管疾病风险
  • 批准号:
    7356339
  • 财政年份:
    2007
  • 资助金额:
    $ 12.2万
  • 项目类别:
Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk
反馈治疗强化数据以降低心血管疾病风险
  • 批准号:
    7490943
  • 财政年份:
    2007
  • 资助金额:
    $ 12.2万
  • 项目类别:
MEASURING THE VALUE OF DISEASE MANAGEMENT: RO1 OR CEA?
衡量疾病管理的价值:RO1 还是 CEA?
  • 批准号:
    6541535
  • 财政年份:
    2002
  • 资助金额:
    $ 12.2万
  • 项目类别:
SPECIALTY REFERRALS AMONG CALIFORNIA PHYSICIAN GROUPS
加州医师团体之间的专业推荐
  • 批准号:
    2032175
  • 财政年份:
    1996
  • 资助金额:
    $ 12.2万
  • 项目类别:
CASE-CONTROL STUDY OF MAMMOGRAPHY
乳房X线照相术病例对照研究
  • 批准号:
    2767474
  • 财政年份:
    1996
  • 资助金额:
    $ 12.2万
  • 项目类别:
SPECIALTY REFERRALS AMONG CALIFORNIA PHYSICIAN GROUPS
加州医师团体之间的专业推荐
  • 批准号:
    2546246
  • 财政年份:
    1996
  • 资助金额:
    $ 12.2万
  • 项目类别:
CASE-CONTROL STUDY OF MAMMOGRAPHY
乳房X线照相术病例对照研究
  • 批准号:
    2414305
  • 财政年份:
    1996
  • 资助金额:
    $ 12.2万
  • 项目类别:
EFFECT OF SPECIALTY ON PRIMARY CARE PRACTICE IN AN HMO
专业对 HMO 初级保健实践的影响
  • 批准号:
    2236688
  • 财政年份:
    1994
  • 资助金额:
    $ 12.2万
  • 项目类别:

相似国自然基金

环状RNA翻译的调控网络及其产物的功能研究
  • 批准号:
    31870814
  • 批准年份:
    2018
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
HER2 IRES启动选择性蛋白质翻译在截断型p110-HER2生成中的价值研究
  • 批准号:
    81702585
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
III型内部核糖体进入位点(IRES)介导核糖体对不同翻译起始区识别敏感性的研究
  • 批准号:
    31302100
  • 批准年份:
    2013
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
家蚕传染性软化病病毒翻译机制及侵染机制的研究
  • 批准号:
    31172262
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
茶尺蠖小RNA病毒内部核糖体进入位点的结构与功能研究
  • 批准号:
    30670084
  • 批准年份:
    2006
  • 资助金额:
    26.0 万元
  • 项目类别:
    面上项目

相似海外基金

ART: American University Translating Research into Action Center (TRAC)
ART:美国大学将研究转化为行动中心 (TRAC)
  • 批准号:
    2331399
  • 财政年份:
    2024
  • 资助金额:
    $ 12.2万
  • 项目类别:
    Cooperative Agreement
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk
PBPK 建模
  • 批准号:
    10706040
  • 财政年份:
    2023
  • 资助金额:
    $ 12.2万
  • 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
  • 批准号:
    10761602
  • 财政年份:
    2023
  • 资助金额:
    $ 12.2万
  • 项目类别:
Harmonizing and Integrating Nursing Data into Multidisciplinary Datasets to Evaluate Hospital Care and Readmissions of Older Adults with Alzheimer's Disease-Related Dementias
将护理数据协调并整合到多学科数据集中,以评估患有阿尔茨海默病相关痴呆症的老年人的医院护理和再入院情况
  • 批准号:
    10789306
  • 财政年份:
    2023
  • 资助金额:
    $ 12.2万
  • 项目类别:
Integrating personal values into primary care for Veterans with multimorbidity
将个人价值观融入患有多种疾病的退伍军人的初级保健中
  • 批准号:
    10538185
  • 财政年份:
    2023
  • 资助金额:
    $ 12.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了